Education

Faculty members in the infectious diseases division provide medical students, internal medicine house staff and ID fellows with the opportunity to obtain information on basic microbiology, diagnostic bacteriology and virology, appropriate use of antimicrobial agents, host factors important to pathogenesis of infection, clinical diagnosis and management of infectious illness, including HIV, and infection control procedures in the prevention of nosocomial infections. Regular student/house staff/fellow conferences (see above) are conducted to provide the medical students, internal medicine residents and ID fellows the opportunity to acquire the principles of diagnosis and management of infectious diseases.

A busy consultative service has been established at Memorial Hermann Hospital-Texas Medical Center where a fellow in infectious diseases, two medical residents, and two fourth-year medical students make up a team under the direction of one of the faculty members. Faculty are also active in teaching at LBJ hospital, Thomas Street Clinic (HIV care), UT Professional Building (outpatient ID) and the West Loop Clinic (travel medicine). Our colleagues at M.D. Anderson Cancer Center have four consultative teaching services: Hematology, Solid Tumors, ICU, and Leukemia.

Division of Infectious Diseases faculty have frequently been awarded the Dean’s Teaching Award for teaching excellence.

Research

Faculty of the Division of Infectious Diseases conduct a wide range of well funded research. The Division also has strong collaborative relationships with colleagues in other schools and departments that bring together multi-disciplinary research teams to investigate the problems of infectious diseases. One of the cross collaborative efforts is the Center for the Study of Emerging and Re-emerging Pathogens which includes faculty in the Department of Micro and Molecular Genetics, Department of Pathology, and the Department of Pediatrics. Another collaborative effort brings together faculty of both UT and Baylor Medical Schools and the UT School of Public Health. Basic and clinical research in the division includes studies of the mechanisms and molecular epidemiology of antimicrobial resistance, fungal diseases, bacterial pathogenesis, diarrheal diseases including cryptosporidium, pharmacokinetics, and HIV/AIDS. Funding sources for this research include NIH, pharmaceutical companies and other grants. Colleagues at MD Anderson Cancer Center are likewise well funded and productive in research (see website for details).

Infectious Disease Fellows are encouraged to pick a research mentor early in their fellowship. Fellows are expected to complete a project during their first year in time to submit an abstract to either the annual meeting of the Infectious Disease Society of America or the Interscience Conference on Antimicrobial Agents and Chemotherapy. Fellows abstracts are frequently accepted for presentation and travel grants are commonly awarded.

Past Fellow Graduates

Graduation Year 2010

Fadi Al Akhrass, Leyla Best, Javier Cairo, Marcela Campo, Sujatha Krishnan, Nicolas Melgarejo, Karen Vigil, Clay Watson

Graduation Year 2009

Saud Ahmed, Marcela Campo, Jose Flores Figueroa, Georgiana Georgescu, John Granger, Clinton Haley, Christelle Kassis, Roshan Lewis, Sherri Onyiego

Graduation Year 2008

Cesar Arias, Georgios Chamilos, Georgiana Georgescu, Solomon Ghide, Elizabeth Ramos, Karen Vigil

Graduation Year 2007

Danny Ghannam, Kevin Grimes, Andrea Holmes, Roshan Lewis, Harrys Torres, Souad Yousseff

Graduation Year 2006

Halim Aboufaycal, Cesar Arias, Mona Kapadia, Ghazi Ghanem, Charles Sims

Graduation Year 2005

Stephanie Lee, Lisa Armitige, Shoaib Ansari, Gabriel Aisenberg, Padma Kumashi, Mallika Kamana, Samuel Maghidman*

Publications of Infectious Disease fellows, who graduated in 2005 or later

• Ghide S, Jiang Y, Hachem R, Chaftari AM, Raad I. Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered? Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):153-6.
• Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, Dupont HL, Adachi JA. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 1;50(3):374-80.
• Campo M, Phung MK, Ahmed R, Cantey P, Bishop H, Bell TK, Gardiner C, Arias CA. A woman with HIV infection, brain abscesses, and eosinophilia. Clin Infect Dis. 2010 Jan 15;50(2):239-40, 276-7.
• Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect. 2010 Feb 4.
• Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, Neumann JL, Raad II, Chemaly RF. Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab. Biol Blood Marrow Transplant. 2010 Mar 18
• Ericsson CD, Melgarejo NA, Jelinek T, McCarthy A; International Society of Travel Medicine Clinical Research Group Travelers' preferences for the treatment and prevention of acute diarrhea. J Travel Med. 2009 May-Jun;16(3):172-8
• Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I. Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol. 2009 Oct;47(10):3255-60.
• Granger JM, Kontoyiannis DP. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer. 2009 Sep 1;115(17):3919-23.
• Ramos ER, Hachem R, Youssef S, Fang X, Jiang Y, Raad I. The crucial role of catheters in micrococcal bloodstream infections in cancer patients. Infect Control Hosp Epidemiol. 2009 Jan;30(1):83-5.
• Georgescu G, Chemaly RF. Palivizumab: where to from here? Expert Opin Biol Ther. 2009 Jan;9(1):139-47. Review.
• Singh KV, Lewis RJ, Murray BE. Importance of the epa locus of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract infection. J Infect Dis. 2009 Aug 1;200(3):417-20.
• Vigil KJ, Adachi JA, Aboufaycal H, Hachem RY, Reitzel RA, Jiang Y, Tarrand JJ, Chemaly RF, Bodey GP, Rolston KV, Raad I. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 2009 Nov;37(9):741-5.
• Ostrosky-Zeichner L, Pappas PG, Shoham S, Reboli A, Barron MA, Sims C, Wood C, Sobel JD. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses. 2009 Jul 21
• Ghannam DE, Rodriguez GH, Raad II, Safdar A. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):253-9.
• Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis. 2009 Oct 15;49(8):1187-94.
• Vigil KJ, Jiang ZD, Chen JJ, Palumbo KL, Galbadage T, Brown EL, Yiang J, Koo H, DuPont MW, Ericsson C, Adachi JA, DuPont HL. Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas. Am J Trop Med Hyg. 2009 Apr;80(4):606-8.
• Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, Belkind-Gerson J, Martinez-Sandoval FG, Okhuysen PC. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. 2008 Aug;79(2):210-4.
• Georgescu G, Isola IM, Youssef S, Adachi J, Rolston K. Disseminated salmonellosis in a patient treated with temozolomide. J Infect. 2008 Nov;57(5):414-5. Epub 2008 Aug 19.
• Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan;93(1):157-8.
• Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15;112(6):1282-7.
• Lewis RJ, Mohr JF 3rd. Dysglycaemias and fluoroquinolones. Drug Saf. 2008;31(4):283-92. Review.
• Lewis R, Hogan H, Howell A, Safdar A. Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection. Leuk Lymphoma. 2008 Jan;49(1):163-5.
• Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol. 2008 Jun;190(6):1605-9.
• Grimes KA, Mohamed JA, Dupont HL, Padda RS, Jiang ZD, Flores J, Belkind-Gerson J, Martinez-Sandoval FG, Okhuysen PC. PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea. J Clin Microbiol. 2008 Jul;46(7):2227-30.
• Ghanem G, Hachem RY, Chemaly RF, Dvorak T, Hulten K, Graviss L, Raad II. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control. 2008 Nov;36(9):656-60.
• Bourgogne A, Garsin DA, Qin X, Singh KV, Sillanpaa J, Yerrapragada S, Ding Y, Dugan-Rocha S, Buhay C, Shen H, Chen G, Williams G, Muzny D, Maadani A, Fox KA, Gioia J, Chen L, Shang Y, Arias CA, Nallapareddy SR, Zhao M, Prakash VP, Chowdhury S, Jiang H, Gibbs RA, Murray BE, Highlander SK, Weinstock GM. Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol. 2008;9(7):R110.
• Arias CA, Vallejo M, Reyes J, Panesso D, Moreno J, Castañeda E, Villegas MV, Murray BE, Quinn JP. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.J Clin Microbiol. 2008 Mar;46(3):892-6.
• Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther. 2008 Oct;6(5):637-55. Review.
• Arias CA, Rincon S, Chowdhury S, Martínez E, Coronell W, Reyes J, Nallapareddy SR, Murray BE. MRSA USA300 clone and VREF--a U.S.-Colombian connection? N Engl J Med. 2008 Nov 13;359(20):2177-9.
• Mohamed JA, DuPont HL, Jiang ZD, Belkind-Gerson J, Figueroa JF, Armitige LY, Tsai A, Nair P, Martinez-Sandoval FJ, Guo DC, Hayes P, Okhuysen PC. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis. 2007 Apr 1;44(7):945-52.
• Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DP. Role of mini-host models in the study of medically important fungi. Lancet Infect Dis. 2007 Jan;7(1):42-55. Review.
• Lewis RE, Chamilos G, Prince RA, Kontoyiannis DP. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Antimicrob Agents Chemother. 2007 Mar;51(3):1078-81
• Chamilos G, Lewis RE, Kontoyiannis DP. Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis. Fungal Genet Biol. 2007 Feb;44(2):88-92.
• Torres HA, Chemaly RF. Viral infection or reactivation in patients during treatment with dasatinib: a call for screening? Leuk Lymphoma. 2007 Dec;48(12):2308-9.
• Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica. 2007 Sep;92(9):1216-23.
• Torres HA, Arduino RC. Fosamprenavir calcium plus ritonavir for HIV infection. Expert Rev Anti Infect Ther. 2007 Jun;5(3):349-63. Review.
• Torres HA, Barnett BJ, Arduino RC. Alopecia associated with ritonavir-boosted atazanavir therapy. AIDS. 2007 Jun 19;21(10):1391-2.
• Torres HA, Bull L, Arduino RC, Barnett BJ. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol. 2007 Jun;102(6):1334-5.
• Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar A, Raad II. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007 Apr 1;44(7):964-7.
• Torres HA, Barnett BJ, Arduino RC. Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency. Clin Infect Dis. 2007 Mar 15;44(6):887-8.
• Shukrallah B, Hanna H, Hachem R, Ghannam D, Chatzinikolaou I, Raad I. Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Diagn Microbiol Infect Dis. 2007 Aug;58(4):453-7.
• Sims CR, Ostrosky-Zeichner L. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch Med Res. 2007 Jan;38(1):90-3.
• Ghanem GA, Boktour M, Warneke C, Pham-Williams T, Kassis C, Bahna P, Aboufaycal H, Hachem R, Raad I. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore). 2007 Jan;86(1):54-60.
• Ghanem G, Adachi J, Han XY, Raad I. Central venous catheter-related Streptomyces septic thrombosis. Infect Control Hosp Epidemiol. 2007 May;28(5):599-601.
• Kapadia M, Rolston KV, Han XY. Invasive Streptomyces infections: six cases and literature review. Am J Clin Pathol. 2007 Apr;127(4):619-24.
• Ghanem GA, Boktour M, Warneke C, Pham-Williams T, Kassis C, Bahna P, Aboufaycal H, Hachem R, Raad I. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore). 2007 Jan;86(1):54-60.
• Aboufaycal H, Sader HS, Rolston K, Deshpande LM, Toleman M, Bodey G, Raad I, Jones RN. blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program. J Clin Microbiol. 2007 Feb;45(2):614-5.
• Arias CA, Cortes L, Murray BE. Chaining in enterococci revisited: correlation between chain length and gelatinase phenotype, and gelE and fsrB genes among clinical isolates of Enterococcus faecalis. J Med Microbiol. 2007 Feb;56(Pt 2):286-8.
• Arias CA, Singh KV, Panesso D, Murray BE Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates. Antimicrob Agents Chemother. 2007 Jun;51(6):2043-7.
• Arias CA, Singh KV, Panesso D, Murray BE. Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model. J Antimicrob Chemother. 2007 Sep;60(3):594-8
• Arias CA, Torres HA, Singh KV, Panesso D, Moore J, Wanger A, Murray BE. Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis. 2007 Nov 15;45(10):1343-6.
• Arias CA, Robredo B, Singh KV, Torres C, Panesso D, Murray BE Rapid identification of Enterococcus hirae and Enterococcus durans by PCR and detection of a homologue of the E. hirae mur-2 Gene in E. durans. J Clin Microbiol. 2006 Apr;44(4):1567-70
• Torres HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol. 2006 Feb;27(2):195-7.
• Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar;6(5):393-8.
• Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 2006 Jan;50(1):96-103.
• Lionakis MS, Chamilos G, Lewis RE, Wiederhold NP, Raad II, Samonis G, Kontoyiannis DP. Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Antimicrob Agents Chemother. 2006 Jan;50(1):294-7.
• Chamilos G, Lewis RE, Kontoyiannis DP. Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin. Antimicrob Agents Chemother. 2006 Feb;50(2):744-7.
• Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DP. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis. 2006 Apr 1;193(7):1014-22. Epub 2006 Feb 28. Erratum in: J Infect Dis. 2006 Nov 1;194(9):1342.
• Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006 Jul;91(7):986-9.
• Kumashi PR, Safdar A, Chamilos G, Chemaly RF, Raad II, Kontoyiannis DP. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review. Clin Microbiol Infect. 2006 Jul;12(7):621-6.
• Chamilos G, Kontoyiannis DP. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine Curr Opin Infect Dis. 2006 Aug;19(4):380-5. Review.
• Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis. 2006 Dec 15;43(12):1580-4.
• Sims CR, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J Clin Microbiol. 2006 Jun;44(6):2105-8.
• Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec;5(12):775-85. Review
• Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005 Apr 15;191(8):1350-60
• Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005 Jul 1;41(1):60-6.
• John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect. 2005 Jul;11(7):515-7. Review.
• Lionakis MS, Lewis RE, Chamilos G, Kontoyiannis DP. Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy. Pharmacotherapy. 2005 Sep;25(9):1174-80.
• Chamilos G, Kontoyiannis DP. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis. J Infect. 2005 Nov;51(4):e225-8.
• Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updat. 2005 Dec;8(6):344-58.
• Arias, C. A. 2005. Step 3. In Briscoe D.A. (ed.), In Lange Q&A USMLE, McGraw Hill, New York.
• Chemaly, R. F., H. A. Torres, R. Y. Hachem, G. M. Nogueras, E. A. Aguilera, A. Younes, M. A. Luna, G. Rodriguez, J. J. Tarrand, and Raad, II. 2005. Cytomegalovirus pneumonia in patients with lymphoma. Cancer 104:1213-20.
• Cruz, C., J. Moreno, A. Renzoni, M. Hidalgo, J. Reyes, J. Schrenzel, D. Lew, E. Castaneda, and C. A. Arias. 2005. Tracking methicillin-resistant Staphylococcus aureus clones in Colombian hospitals over 7 years (1996-2003): emergence of a new dominant clone. Int J Antimicrob Agents.
• Kamana, M., C. Escalante, C. A. Mullen, S. Frisbee-Hume, and K. V. Rolston. 2005. Bacterial infections in low-risk, febrile neutropenic patients. Cancer 104:422-6.
• Kontoyiannis, D. P., M. Boktour, H. Hanna, H. A. Torres, R. Hachem, and Raad, II. 2005. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer 103:2334-7.
• Kumashi, P., E. Girgawy, J. J. Tarrand, K. V. Rolston, Raad, II, and A. Safdar. 2005. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore) 84:303-12.
• Lee, S. A., A. H. Diwan, M. Cohn, R. Champlin, and A. Safdar. 2005. Cutaneous toxoplasmosis: a case of confounding diagnosis. Bone Marrow Transplant 36:465-6.
• Lionakis, M. S., R. E. Lewis, H. A. Torres, N. D. Albert, Raad, II, and D. P. Kontoyiannis. 2005. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis 52:15-20.
• Nannini, E. C., F. Teng, K. V. Singh, and B. E. Murray. 2005. Decreased virulence of a gls24 mutant of Enterococcus faecalis OG1RF in an experimental endocarditis model. Infect Immun 73:7772-4.
• Panesso, D., L. Abadia-Patino, N. Vanegas, P. E. Reynolds, P. Courvalin, and C. A. Arias. 2005. Transcriptional analysis of the vanC cluster from Enterococcus gallinarum strains with constitutive and inducible vancomycin resistance. Antimicrob Agents Chemother 49:1060-6.
• Philip, A., Z. Odabasi, G. Matiuzzi, V. L. Paetznick, S. W. Tan, J. Warmington, J. H. Rex, and L. Ostrosky-Zeichner. 2005. Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis. J Clin Microbiol 43:4834-5.
• Philip, A., Z. Odabasi, J. Rodriguez, V. L. Paetznick, E. Chen, J. H. Rex, and L. Ostrosky-Zeichner. 2005. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother 49:3572-4.
• Safdar, A., G. Rodriguez, N. Ohmagari, D. P. Kontoyiannis, K. V. Rolston, Raad, II, and R. E. Champlin. 2005. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer 103:731-9.
• Sims, C. R., L. Ostrosky-Zeichner, and J. H. Rex. 2005. Invasive candidiasis in immunocompromised hospitalized patients. Arch Med Res 36:660-71.
• Singh, K. V., S. R. Nallapareddy, E. C. Nannini, and B. E. Murray. 2005. Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditis. Infect Immun 73:4888-94.
• Torres, H. A., D. P. Kontoyiannis, G. P. Bodey, J. A. Adachi, M. A. Luna, J. J. Tarrand, G. M. Nogueras, Raad, II, and R. F. Chemaly. 2005. Gastrointestinal cytomegalovirus disease in patients with cancer: A two decade experience in a tertiary care cancer center. Eur J Cancer 41:2268-79.
• Torres, H. A., V. G. Prieto, Raad, II, and D. P. Kontoyiannis. 2005. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact C. neoformans. Mycoses 48:21-4.